These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9858132)

  • 21. Epidermolysis bullosa acquisita: a clinical disorder of varied etiologies. Two cases and a review of immunologic and other reported findings.
    Wilson BD; Birnkrant AF; Beutner EH; Maize JC
    J Am Acad Dermatol; 1980 Sep; 3(3):280-91. PubMed ID: 7005274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermolysis bullosa acquisita: an autoimmune disease with distinctive immunoultrastructural features.
    Woodley DT; Gammon WR
    Cutis; 1983 Dec; 32(6):521-7. PubMed ID: 6357643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional heterogeneity of immune complexes in epidermolysis bullosa acquisita.
    Gammon WR; Briggaman RA
    J Invest Dermatol; 1987 Nov; 89(5):478-83. PubMed ID: 3668292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid.
    Chan LS; Majmudar AA; Tran HH; Meier F; Schaumburg-Lever G; Chen M; Anhalt G; Woodley DT; Marinkovich MP
    J Invest Dermatol; 1997 Jun; 108(6):848-53. PubMed ID: 9182809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
    Gammon WR; Woodley DT; Dole KC; Briggaman RA
    J Invest Dermatol; 1985 Jun; 84(6):472-6. PubMed ID: 3889170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen.
    Woodley DT; O'Keefe EJ; McDonald JA; Reese MJ; Briggaman RA; Gammon WR
    J Clin Invest; 1987 Jun; 79(6):1826-30. PubMed ID: 3584471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
    Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
    J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The dermo-epidermal junction and its acquired and hereditary pathology. A few recent advances].
    Ortonne JP
    Pathol Biol (Paris); 1992 Feb; 40(2):121-32. PubMed ID: 1608653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered skin basement membrane antigenicity in epidermolysis bullosa.
    Fine JD
    Curr Probl Dermatol; 1987; 17():111-26. PubMed ID: 3297501
    [No Abstract]   [Full Text] [Related]  

  • 30. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
    Peng TK; Nisengard RJ; Levine MJ; Beutner EH
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathology of the basement membrane zone in heritable blistering diseases:: The paradigm of epidermolysis bullosa.
    Uitto J; Has C; Vahidnezhad H; Youssefian L; Bruckner-Tuderman L
    Matrix Biol; 2017 Jan; 57-58():76-85. PubMed ID: 27496350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
    Woźniak K; Kowalewski C
    J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen.
    Woodley DT; Burgeson RE; Lunstrum G; Bruckner-Tuderman L; Reese MJ; Briggaman RA
    J Clin Invest; 1988 Mar; 81(3):683-7. PubMed ID: 3278005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
    Fine JD
    J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disorders of the cutaneous basement membrane zone--the paradigm of epidermolysis bullosa.
    Bruckner-Tuderman L; Has C
    Matrix Biol; 2014 Jan; 33():29-34. PubMed ID: 23917088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lupus band: do the autoantibodies target collagen VII?
    Alahlafi AM; Wordsworth P; Wojnarowska F
    Br J Dermatol; 2004 Mar; 150(3):504-10. PubMed ID: 15030334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adquired epidermolysis bullosa. Immunopathological and ultrastructural studies].
    Mascaró JM; Jorda E; Calap J; Botella R; Febrer I
    Med Cutan Ibero Lat Am; 1978; 6(1):1-7. PubMed ID: 384109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone.
    Has C; Nyström A; Saeidian AH; Bruckner-Tuderman L; Uitto J
    Matrix Biol; 2018 Oct; 71-72():313-329. PubMed ID: 29627521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.